Labenko

Labenko, founded in 2015, is a promising player in the fields of AI, Automation, Robotics, and Machine Learning. Headquartered in Turkey, the company is dedicated to transforming preanalytical processes through cutting-edge technologies. Utilizing AI and robotics, Labenko aims to integrate and automate these processes, eliminating errors and intercepting them at early stages.

The company targets critical preanalytic errors in the medical testing phase, which significantly reduces costs associated with test repetitions and minimizes clinical mistakes. With their innovative approach, Labenko is strategically positioned to offer substantial operational efficiencies and cost savings for healthcare providers.

Though Labenko has not yet attracted its last investment, its pioneering solutions aligned with increasing market demand for automation offer a compelling opportunity for investors focusing on scalable technology impacts in healthcare. Their firm footing in a rapidly evolving industry underscores their potential for future growth.